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A workshop entitled “RNA Control of Neuronal Func-
tion” was recently held in Kfar Blum, Israel. The main
topics discussed at the meeting included neuronal
RNA targeting mechanisms and the contributing
codes and components, translational control mecha-
nisms in dendrites and axons, and the relevance of
these mechanisms for neuronal development, plastic-
ity, and dysfunction.
Kfar Blum, an idyllic kibbutz on the banks of the Jordan
River in Upper Galilee, hosted a workshop in May 2005
on the topic “RNA control of neuronal function.” Orga-
nized by Joel Richter, Robert Singer, and Joel Yisraeli,
the workshop took stock of a scientific field that has
now come of age and, by choosing Israel as the venue,
made a statement that science has no political borders.
This is an appropriate time for taking stock, as the
field of local protein synthesis in neurons is entering its
40th anniversary year. It was in 1965 that for the first
time evidence was published to indicate that proteins
may be synthesized at local sites in dendrites and ax-
ons (reviewed by Kindler et al., 2005). Ironically, for the
next 20 years these ground-breaking observations were
relegated to sleeper status as transcription ruled in
a nucleo-somatocentric world. Perceptions began to
shift only with the discovery of polyribosomes in post-
synaptic microdomains and with the subsequent dis-
covery of specific RNAs (MAP2 mRNA, CaMKIIα mRNA,
BC1 RNA) in dendrites (reviewed by Kindler et al.,
2005). Today, several dozens of dendritic and axonal
RNAs have been identified, and their total number is
estimated at several hundreds (reviewed by Kindler et
al., 2005). How are these RNAs delivered to their desti-
nation sites, how is translation of mRNAs implemented
and regulated at such local sites, and how does locally
regulated protein synthesis contribute to the growth
and plasticity of neurons? These questions currently
constitute some of the major challenges in the field,
and they figured prominently in the discussions at
Kfar Blum.
Early Life
The life of an RNA begins in the nucleus, and early life
experience may influence subsequent development. In
addition to redefining protein coding information, nu-
clear events such as splicing and editing may also im-
pact the way an RNA is subsequently handled in the
cytoplasm. The biogenesis and dynamics of the various
ribonucleoprotein (RNP) particles that are involved in
such nuclear events are thus of considerable interest.*Correspondence: htiedge@downstate.eduFor example, the survival of motor neurons (SMN) com-
plex has recently been identified as a molecular assem-
bly machine that helps organize snRNP biogenesis
(Wan et al., 2005). The SMN complex may play a key
role in cellular RNA metabolism; reduced levels of SMN
protein cause spinal muscular atrophy (SMA). Subcellu-
lar RNA targeting depends on interactions with proteins
within RNP complexes, and it will therefore be impor-
tant to establish whether RNP formation in the nucleus
is a requirement or determinant for subsequent cyto-
plasmic transport.
Interestingly, nuclear mobility of mRNPs appears to
be undirected, i.e., reflecting simple diffusion, as recent
work by the Singer laboratory has shown. Also, as
RNAs destined for export do not seem to express a
preference for particular nuclear pores, the data imply
that targeting elements (also known as zipcodes) speci-
fying recruitment of molecular motors may only be-
come operational in the somatic cytoplasm. However,
the nucleus may remain involved in some aspects of
RNA life even subsequent to nuclear export. After axo-
nal injury, for example, a retrograde signal is relayed to
the nucleus, where it triggers a response. This mecha-
nism has previously been shown to involve local syn-
thesis and subsequent retrograde transport of impor-
tins and, more recently, the retrograde transport of
phosphorylated MAP kinases Erk1 and Erk2 via vimen-
tin-mediated recruitment to importin β (see Perlson et
al., 2005, and references quoted therein).
RNA on the Move
Once an RNA has engaged with the neuronal transport
machinery and is on its way in dendrites, it moves at
speeds up to 1 m/s (O. Steward and M. Kiebler, per-
sonal communication). Axonal transport of RNA has
been reported at similar velocities (Muslimov et al.,
2002), and it thus appears that common mechanisms
may be employed for the long-range transport of RNA
in axons and dendrites. Previously reported lower den-
dritic velocities may reflect multiple mechanisms, in-
cluding participation of both fast and slow molecular
motors, periods of rest, and perhaps moments of oscil-
latory indecision at branch points. It will now be impor-
tant to dissect the various codes that specify RNA tar-
geting, i.e., to axons versus dendrites, to proximal
versus distal domains, and to synaptic versus shaft
microdomains. These destination codes are likely to be
contained in the respective transported RNAs. It will be
a major challenge in the field (or rather a “rich mining
field” in the words of O. Steward) to understand how
multiple motifs within transported RNAs cooperate,
perhaps in modular fashion, to encode targeting com-
petence to diverse neuronal destination sites. We will
also need to understand how spatial information is ex-
pressed in the structural design of RNA motifs and how
such information is decoded by the cellular transport
machinery (Kindler et al., 2005; Smith, 2004).
By definition, cis-acting RNA targeting elements are
recognized by trans-acting factors (TAFs) that mediate,
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Most TAFs that have been described so far—and others
will no doubt be added in the future—belong to one of
three families: hnRNPs, zipcode binding proteins (ZBPs),
or the Staufen family of proteins. Staufen2, a brain-spe-
cific member of the latter family, has been implicated
in RNA transport to dendrites and in dendritic spine
plasticity (M. Kiebler, personal communication). The
ZBP family (also known as IMPs in mammals, Vg1 RBP
in Xenopus, or generally as the VICKZ family of RNA
binding proteins) plays roles in the control of RNA sta-
bility, localization, and translation. In addition, the
VICKZ proteins may participate in the assembly of neu-
ronal RNPs, the composition of which in turn deter-
mines the fate of the RNA. Interestingly, some VICKZ
proteins are deregulated in certain types of cancers
(J. Yisraeli, personal communication).
Talks on trans-acting proteins highlighted the increas-
ingly idiosyncratic nomenclature for cis-acting elements
and TAFs, leading several workshop participants to call
for consolidation. For neuronal RNAs, consensus now
seems to converge on the term “targeting element”
(i.e., DTE for dendritic targeting element, analogously
ATE). Thus, a CaMKIIα DTE would be a segment within
CaMKIIαmRNA that contains a code to signal dendritic
targeting competence, or part of such competence.
Clearly, convergence would likewise be desirable for
TAF nomenclature.
Given the complexities of neuronal RNA transport,
we may anticipate more TAFs to be uncovered in the
future. Proteomics approaches are now being used to
identify protein components of neuronal RNA transport
particles. Such particles, also referred to as granules
if large, have been observed in axons and dendrites.
Transport granules appear to contain several of the pre-
viously identified TAFs as well as novel candidate TAFs
such as DEAD box helicases (Kanai et al., 2004; W.
Sossin, personal communication). Conventional kinesin
(KIF5) was identified as a molecular motor responsible
for the translocation of such particles (Kanai et al.,
2004). Proteomics approaches have recently also been
used to examine nuclear compartments, and work by
the Lamond group (Andersen et al., 2005) has illus-
trated the dynamic nature of cellular microdomains in
general, with implications for mobility and remodeling
at the synapse.
Despite such progress, it has to be conceded that the
identification of neuronal TAFs is not straightforward.
During their life cycles, RNAs are recognized by a
multitude of proteins, many of them performing roles
unrelated to RNA transport. Furthermore, transported
and localized neuronal RNPs should not be seen as
static entities but rather as dynamic structures that
probably undergo frequent remodeling both en route
and at their destinations. Investigators have therefore
been careful to apply stringent criteria to separate the
chaff from the grain, i.e., false positives from bona fide
TAFs, RNA particles, and transport granules. It is hoped
that these efforts will soon allow us to begin under-
standing the sequence of events that, starting with the
recognition of transport-encoding RNA motifs by TAFs,





























































so Multitask or Not—It’s Still a Question
re targeted mRNAs translated during transport? While
ome transported mRNAs may be translationally in-
ctive, it seems likely that distinct mechanisms may be
n place for different mRNAs. A transported mRNA may
ot be accessible to the translational machinery, as it is
ompacted in particles that may lack essential factors.
lternatively or in addition, specific mRNAs may be
ctively repressed while en route. ZBP1, for example,
s a TAF that is required for the localization of β-actin
RNA; it may simultaneously act as its translational re-
ressor (S. Hüttelmaier and R. Singer, personal com-
unication). Alternatively, mRNAs may be translated
uring transport, although in most cases this would ap-
ear unlikely because of steric hindrance by the bound
ransport machinery. However, an SRP-like mecha-
ism—i.e., initiation followed by translational arrest—is
ertainly a possibility. Whatever the mechanism, it may
e important for a neuron, with its highly mosaic post-
ynaptic microdomains, to prevent ectopic translation
f mRNAs en route, i.e., to suppress production of pro-
eins in the wrong place or at the wrong time (Job and
berwine, 2001). Again, such a requirement may not
pply to all mRNAs, and local production of some pro-
eins may be tolerated by a cell even if it occurs ectopi-
ally—i.e., not when and where needed—although in-
ut specificity (see below) may be lost in such cases.
Future work will aim at understanding how RNA re-
ease from transport particles is controlled at local des-
ination sites and how released RNAs are subsequently
nchored at those sites. Recent results implicate CaM-
II and MAP kinases in the signaling pathways that pro-
ote selective docking of Arc mRNA at stimulated syn-
pses (O. Steward, personal communication). Upon
ocking, control of translational status would be ex-
ected to be handed over from transport particles to
ocal, e.g., synaptic, authority.
ilence Is Golden
he central dilemma in neuronal plasticity lies in the
act that, for the long-term modulation of synaptic
trength, two key requirements have to be met. On one
and, the signal transduction events that are triggered
y synaptic activation have to result in changes in gene
xpression, i.e., the synthesis of new proteins. On the
ther hand, these changes have to be implemented in
n input-specific manner, i.e., specific to a stimulated
ynapse or to a local cluster of synapses. Such imple-
entation is difficult to envision with a conventional
oma-based translation system. The dilemma is of
ourse immediately overcome if translation can be con-
rolled locally, e.g., at synaptic sites. Candidate mecha-
isms for local translational control were one of the fo-
al points in the discussions at Kfar Blum.
Two modes are usually distinguished in general
ranslational control (Gebauer and Hentze, 2004): global
ontrol, which affects all or most mRNAs in a cell; and
RNA-specific control, which affects individual mRNAs
r groups of mRNAs. This dichotomy is mirrored by lo-
al control mechanisms at the synapse, with one im-
ortant distinction: synapse-wide control would affect
ll or most mRNAs at that synapse (and perhaps at
ome neighboring synapses) but not mRNAs that are
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15located elsewhere in the same neuron. The comple-
ment of proteins that is synthesized under synapse-
wide control will be determined by the repertoire of
mRNA species—however large or small—that is pres-
ent at a particular synapse and therefore by the spe-
cifics of targeting and recruitment mechanisms that ap-
ply to that synapse. Specificity is thus spatial in nature
in this mode, i.e., is derived from location. Conse-
quently, this mode may be useful whenever synapse-
wide but location-specific changes are necessary, for
instance, when an entire microdomain is strengthened
or growing following stimulation.
Candidate factors that are involved in synapse-wide
control have been identified. One such factor, the neu-
ronal form of eukaryotic initiation factor 4E (eIF4E) binding
protein (4E-BP2), reversibly inhibits eIF4E. Knockout ani-
mals that do not express 4E-BP2 (and are thus presum-
ably initiation derepressed) exhibit learning deficits and
have altered requirements for the induction of long-
term potentiation (LTP) (E. Klann and N. Sonenberg,
personal communication). Untranslated dendritic BC1
RNA is a translational repressor that inhibits eIF4F/
PABP-mediated formation of 48S initiation complexes
(reviewed by Kindler et al., 2005). Both mechanisms
would preferentially affect translation of mRNAs with
long, complex 5# UTRs (mRNAs that often encode pro-
teins involved in growth and development), as they re-
quire significant unwinding for initiation. How is initia-
tion of synaptic translation controlled? Recent work
suggests that miniature excitatory synaptic events
(minis) participate in the modulation of local protein
synthesis. While prolonged blockade of action poten-
tials slightly reduces local protein synthesis, blockade
of minis themselves actually results in increased den-
dritic translation, possibly involving differential regula-
tion of GluR subunits (Sutton et al., 2004). Regulation
of local translation by minis thus appears to be a means
for a synapse to define and adjust baseline transla-
tional activities.
Local translational control is also implemented in ax-
ons. Axonal growth cones respond to chemotropic gra-
dients of netrin-1 or Sema3A in a translation-dependent
manner (Piper and Holt, 2004). These signals activate
different MAP kinase pathways, converging on the
mammalian target of rapamycin (mTOR) and resulting
in an increase in phosphorylation of eIF4E and 4E-BP1.
Local translation, a precondition for the subsequent
growth cone steering response, is thus initiated after
eIF4E derepression (Piper and Holt, 2004). Local trans-
lation also appears to be important for axonal regenera-
tion (Perlson et al., 2005; Willis et al., 2005).
Examples of mRNA-selective control were also dis-
cussed at Kfar Blum. Zinki, for instance, is an RNA
binding protein that specifically interacts with Arc
mRNA and may repress its translation (D. Kuhl, per-
sonal communication). Group-selective control is ex-
emplified by the cytoplasmic polyadenylation element
(CPE) mechanism. CPE-containing mRNAs (including
CaMKIIαmRNA) have to be polyadenylated in the cyto-
plasm to become translationally competent, a mecha-
nism that requires phosphorylation of the CPE binding
protein CPEB. Nonphosphorylated CPEB interacts with
maskin, which represses translation by binding to
eIF4E. This pathway recapitulates the situation in de-veloping oocytes, where certain mRNAs remain transla-
tionally silenced prior to maturation (Richter and Lo-
renz, 2002). In Aplysia, a glutamine-rich N-terminal
extension in a neuronal isoform of CPEB can undergo
a self-perpetuating conformational change that is remi-
niscent of prions. It is suggested that conversion of
Aplysia CPEB to such a prion-like state at a stimulated
synapse may differentially activate translation of CPE-
containing mRNAs and thus help maintain changes that
are associated with memory storage (reviewed by
Shorter and Lindquist, 2005).
Much remains to be learned. For example, we do not
know the relative concentrations of mRNAs and trans-
lational machinery (i.e., ribosomes, translation factors)
at synapses. Machinery components may be limiting at
distant dendritic sites, and local mRNAs would there-
fore have to compete for them. As discussed below, it
is also likely that many or most mRNAs at a synapse
are, at least temporarily, translationally repressed, al-
lowing for “controlled competition” and thus for mRNA/
machinery stoichiometries that differ from those that
apply to steady-state conditions in the soma.
It is striking that in all cases described above, the
translational regulator is a repressor. This appears to
be a consequence of the fact that the default state of
translation, in contrast to transcription, is “on.” Thus,
an mRNA released at the synapse will be translated un-
less repressed. If the overriding consideration is to
avoid translation at the wrong time, local translation at
many synapses will be maintained at a repressed basal
level until an appropriate signal is received. From what
we learned at Kfar Blum, it appears that multiple trans-
lation repression mechanisms, some of them over-
lapping and intersecting, are in place at the synapse
(Figure 1). Why multiple repression mechanisms? If de-
repression is all it takes to activate local protein synthe-
sis, multiple repressors may be required to ensure that
derepression is not triggered inappropriately or prema-
turely. Accidental runaway translation may not be toler-
ated at the synapse, as it could set off a self-enforcing
feedforward cascade that may be hard to control and
result in plasticity catastrophe. A properly maintained
local repression-derepression balance may therefore
be key to translational control at the synapse.
Still, even if redundant, local mechanisms may at
times become insufficient or defective. Several contri-
butions at Kfar Blum addressed the relationship be-
tween RNA control and disease. Altered splicing has
been implicated in disease: repressed splicing of SMN2
exon 7 is associated with SMA (Kashima and Manley,
2003), while Nova, an RNA binding protein that partici-
pates in the splicing of neuronal mRNAs, is associated
with paraneoplastic disease (Ule et al., 2005). Alter-
ations in neuronal translation may also result in dis-
ease. The fragile X mental retardation protein (FMRP)
has been suggested to act as a translational repressor
in dendrites, and its physiological target(s) and mode
of action are of considerable current interest. In re-
sponse to mGluR activation, FMRP particles are trans-
located to dendrites where they colocalize with ribo-
somes (Antar et al., 2005). Purkinje cell-specific Fmr1
knockout mice show deficits in eye-blink conditioning
(a phenotype that is also observed in fragile X patients),
suggesting that cerebellar dysfunction may contribute
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16Figure 1. Repressors-R-Us: Translational Control at the Synapse
Multiple repression mechanisms are in operation in postsynaptic
microdomains. Diverse repressors—which may be RNAs or pro-
teins—may target specific mRNAs, initiation factors, and initiation
or elongation complexes. For any given mRNA, all relevant repres-
sors have to be removed or inactivated before the cognate protein
can be synthesized following trans-synaptic stimulation. The rela-
tive concentrations of ribosomes, mRNAs, initiation factors, elon-
gation factors, etc., at the synapse are unknown. Illustration pro-
































4to the disease (Koekkoek et al., 2005). Some of the be-
havioral and neuronal abnormalities that are observed
in Fmr1-negative mice are alleviated under enriched-
environment conditions (Restivo et al., 2005). In sum-
mary, there has been progress recently in probing the
significance of RNA control mechanisms in neuronal
function and dysfunction. Equally fascinating are the
roles and fates of small untranslated RNAs in neurologi-
cal disease (A. Krichevsky, personal communication).
An evolutionary perspective on RNA control was pro-
vided by J. Brosius. Although they are a class of mole-
cules older than proteins, new RNAs continue to
evolve. Retroposition (conversion of RNA to DNA) is
one mechanism that likely has precipitated many
changes in gene structure and expression. These
changes have in turn served—and continue to serve,
as can for example be seen with untranslated BC
RNAs—as a genomic driving force in neural evolution
and speciation.
It has been 11 years since the first FASEB meeting
on RNA localization was held at UC Santa Cruz in July
1994. At that time, appreciation of RNA control was in
its infancy in the field of synaptic plasticity, as was in-
terest in long-term potentiation in the field of transla-
tional control. We have come a long way since that con-
stituting Santa Cruz meeting, and the field has seen
dramatic development over the last 10 years. Today,
the challenges are clear, but so is the general future
direction. We are looking forward to the next decade of
RNA control in neurons.
































ran be found at www.embo-rna-neurons.com. My apo-
ogies to all those whose contributions could not be
uoted because of space limitations.
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